Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Elizeth García-Iglesias"'
Autor:
Hugo Nodarse-Cuní, Enrique Arús-Soler, Luis L Rivera-Reimón, Marlén Pérez-Lorenzo, Marcia Samada-Suárez, Waldo O García-Ferrera, Yoan A Sánchez-Rodríguez, Daymela Pupo-Oliveros, Angel Obregón-Moreno, Ivis Umpierre-García, Orelvis Martínez-Martínez, Antonio Moret-Pérez, Yaimé González-González, Yuliet Bermúdez-Hernández, Elizeth García-Iglesias, Odalys C Lazo-Diago, Pedro López-Saura
Publikováno v:
Biotecnología Aplicada, Vol 29, Iss 3, Pp 184-188
The treatment of chronic hepatitis C with interferon alpha (IFN-a) is widely used. However, the relapse rate is high, and sustained response is only in 10-20%. A combined treatment based on the synergic antiviral effects described for IFN-a and ribav
Externí odkaz:
https://doaj.org/article/f3c2c2e4ff484170b52c4545adaabdd3
Autor:
Carmen M Valenzuela-Silva, Elizeth García-Iglesias, José I Fernández-Montequín, Amaurys del Río-Martín, Isis Belkis Yera Alos, Ángela D. Tuero-Iglesias, Odalys González-Díaz, Pedro Lopez-Saura
Publikováno v:
Diabetes Care
OBJECTIVE To determine if partial wound closure surrogate markers proposed for neuropathic, small diabetic foot ulcers (DFUs) can be extended to advanced lesions and if the development of granulation tissue can be used to predict complete healing. RE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::601c6391d0c5aa14e57248849eb1cda0
https://doi.org/10.2337/dc12-1323
https://doi.org/10.2337/dc12-1323
Autor:
Elizeth García Iglesias, Carmen Valenzuela Silva, Hilev Larrondo Muguercia, Abel Magdariaga Figuerola, Emma Domínguez Alonso, Wim A. Buurman, Ingrid Rodríguez Alonso, Manuel de J. Araña Rosaínz, Alfredo Sánchez Valdivia, Miriam Ojeda Ojeda
Publikováno v:
Inflammation Research, 60(3), 289-297. Birkhauser Verlag Basel
OBJECTIVE AND DESIGN: To evaluate the association of pro-inflammatory mediators with organ dysfunction and adverse outcome in intra-abdominal sepsis patients. SUBJECTS: Twenty-one patients admitted to the Intensive Care Unit (ICU) were prospectively
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa8a90600c7e592af9732069ed6f68ab
https://doi.org/10.1007/s00011-010-0267-4
https://doi.org/10.1007/s00011-010-0267-4
Autor:
Ernesto L Mola, Sergio Bermúdez-Rojas, Felix Rosales, Blas Y Betancourt, Mayte Ramírez-Navas, Elizeth García-Iglesias, Gisselle Leyva-Gonzalez, José I Fernández-Montequín, Luis H Martinez, Jorge Berlanga-Acosta, Marianela Garcia-Siverio, Katia Galán-Naranjo, Ricardo Silva-Rodriguez
Publikováno v:
Int Wound J
Previous studies have shown that an epidermal growth factor-based formulation (Heberprot-P) can enhance granulation of high-grade diabetic foot ulcers (DFU). The aim of this study was to explore the clinical effects of this administration up to compl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9eb4caa18a99e9907a4e927c3d1e05c
https://doi.org/10.1111/j.1742-481x.2008.00561.x
https://doi.org/10.1111/j.1742-481x.2008.00561.x
Autor:
Iraldo Bello-Rivero, Dania Vazquez-Blomquist, Mileidys Cabrera-Placeres, Yoandy Izquierdo-Toledo, Tania I Carballo-Treto, Idrian García-García, Nailet Castro-Basart, Josanne Soto-Matos, Yaquelin Duncan-Roberts, Sonia E Collazo-Caballero, Elizeth García-Iglesias, Egla E Santely-Pravia, Alieski Cruz-Ramírez, Cristian Alfonso-Alvarado, Ángela D. Tuero-Iglesias, Yanelda García-Vega
Publikováno v:
BMC Pharmacology & Toxicology
Background The synergistic combination of interferon (IFN) alpha-2b and IFN gamma results in more potent in vitro biological effects mediated by both IFNs. The aim of this investigation was to evaluate by first time the pharmacokinetics and pharmacod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ca8c2c8964f3de88fe55c00ca393ecc
https://doi.org/10.1186/2050-6511-13-20
https://doi.org/10.1186/2050-6511-13-20
Autor:
Elizeth García-Iglesias, Blas Y Betancourt, Giset Jiménez-López, Leovaldo Alvarez-Falcón, Carmen M Valenzuela-Silva, Francisco Debesa-García, Francisco Hernández-Bernal, María A Marrero-Miragaya, Tania González-López, Pedro Lopez-Saura
Publikováno v:
BMC Clinical Pharmacology
Background Streptokinase (SK) is an effective fibrinolytic agent for the treatment of acute myocardial infarction (AMI). The objective of the present study was to assess the adverse drug reactions (ADRs) associated with intravenous recombinant SK in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efcc6bb44050f55329d156fe95db233c
https://doi.org/10.1186/1472-6904-5-5
https://doi.org/10.1186/1472-6904-5-5
Autor:
Carmen M Valenzuela-Silva, Elizeth García-Iglesias, Neobalis Franco-Pérez, William Savigne-Gutierrez, Pedro Lopez-Saura, Lourdes Morejón-Vega, Heriberto Artaza-Sanz, Cecilio González-Benavides, Blas Y Betancourt, José I Fernández-Montequín, Ricardo Silva-Rodriguez, Ena Infante-Cristiá, Jorge Berlanga-Acosta, Osvaldo Eliseo-Musenden
Publikováno v:
Int Wound J
To investigate the efficacy and safety of recombinant human epidermal growth factor (rhEGF) in advanced diabetic foot ulcers (DFU) A double-blind trial was carried out to test two rhEGF dose levels in type 1 or 2 diabetes patients with Wagner's grade
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb0672ebeef04ace1e60facbbae9ee2b
https://doi.org/10.1111/j.1742-481x.2007.00344.x
https://doi.org/10.1111/j.1742-481x.2007.00344.x
Autor:
Hugo Nodarse-Cuní, Enrique Arús-Soler, Luis L Rivera-Reimón, Marlén Pérez-Lorenzo, Marcia Samada-Suárez, Waldo O García-Ferrera, Yoan A Sánchez-Rodríguez, Daymela Pupo-Oliveros, Angel Obregón-Moreno, Ivis Umpierre-García, Orelvis Martínez-Martínez, Antonio Moret-Pérez, Yaimé González-González, Yuliet Bermúdez-Hernández, Elizeth García-Iglesias, Odalys C Lazo-Diago, Pedro López-Saura
Publikováno v:
Biotecnología Aplicada, Vol 29, Iss 3, Pp 184-188
The treatment of chronic hepatitis C with interferon alpha (IFN-a) is widely used. However, the relapse rate is high, and sustained response is only in 10-20%. A combined treatment based on the synergic antiviral effects described for IFN-a and ribav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::ce1350501a56ee90114742524b979d8a
http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1027-28522012000300005&lng=en&tlng=en
http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1027-28522012000300005&lng=en&tlng=en